Derniers articles sur la conformité des Produits Pharmaceutiques
Comprendre les 5 types de DMF de la FDA : comment les utiliser, ce qu’il faut éviter et comment transformer les soumissions confidentielles en actifs réglementaires stratégiques.
Read More
Maîtrisez les soumissions DMF avec un formatage prêt pour la FDA, une stratégie de cycle de vie et une coordination des sponsors pour gagner en rapidité, en confiance et en conformité.
Read More
Apprenez à soumettre, structurer et maintenir un fichier maître de médicament (Drug Master File, DMF) pour la conformité à la FDA, y compris le formatage eCTD et les distinctions globales.
Read More
Comparez le dossier permanent des médicaments de la FDA avec des équivalents mondiaux tels que ASMF, CEP et J-DMF pour rationaliser les soumissions réglementaires sur les principaux marchés.
Read More
Découvrez les règles d’enregistrement et de liste des établissements pharmaceutiques de la FDA, l’utilisation de la FEI et comment rester en conformité avec la norme 21 CFR 207 pour l’accès au marché américain.
Read More
Produits Pharmaceutiques Regulations FAQ
For Drug Establishments, who must register?
Domestic or foreign owners or operators of establishments that manufacture, prepare, propagate, compound, or process a drug or drugs and are not considered exempt must register their facility with FDA, according to the Code of Federal Regulations. In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is required for drug establishment registration?
Information you must submit as part of your FDA facility registration with your Structured Product Labeling (SPL) file includes:
- Company Name and full address of each establishment
- Name, address, phone number, and email address of official contact
- Type of operation(s) performed at each establishment
- DUNS number
- Facility Establishment Identifier (when assigned)
Non. U.S. establishments must also include:
- Name designated U.S. Agent
- Name of each importer known to the establishmentName of each agent, broker, or other entity, other than a carrier used to facilitate the import of their drug into the U.S.
- Include DUNS number, phone number and email address for each entry.
See Title 21 of the Code of Federal Regulations for a complete list.
Who must provide drug listings?
All drug establishments that are not considered exempt and must register with FDA must also submit initial listing information for all drugs in commercial distribution at the time of their original FDA facility registration, according to the Code of Federal Regulations.
In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is submitted for a drug listing?
Information you must submit as part of your FDA drug listing includes:
- Name of establishment(s) manufacturing or processing the listed drug and the type of operation(s) performed
- DEA schedule
- Route(s) of administration
- Dosage Form
- Ingredients (active with strength amounts and inactive)
- Marketing information (e.g., category, start/stop date)
- Information related to the application (e.g., type and year of approval) or OTC monograph citation number
- Package size and type
- NDC Product Code for a source drug repacked or relabeled
- Unique Ingredient Identifiers (UNII) and other code sets
- Distinctive Characteristics of certain listed drugs
- Labeling artwork
- National Drug Code (NDC) number
What is a master file?
A Master File is a secure, confidential submission of proprietary product data to a regulatory agency, such as the U.S. Food and Drug Administration (FDA), or the National Medical Products Association (NMPA) in China.